Doppler-guided transanal hemorrhoidal dearterilization versus conventional hemorrhoidectomy for treatment of hemorrhoids - early and long-term postoperative results.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
10 Jan 2019
Historique:
received: 02 11 2017
accepted: 02 01 2019
entrez: 12 1 2019
pubmed: 12 1 2019
medline: 12 2 2019
Statut: epublish

Résumé

A variety of effective methods for treatment of hemorrhoids has been proposed. In recent years, there has been an increasing number of studies comparing transanal hemorrhoidal dearterilization (THD) and conventional hemorrhoidectomy (CH), but the focus of most studies has been about the early postoperative results. The data about long-term outcomes is still limited. We aimed to compare Doppler-guided THD and CH with regard to early and long-term postoperative results. The conducted prospective research included 287 patients who underwent CH (167 cases) or Doppler-guided THD with mycopexy (120 patients) between November 2010 and December 2015. Information on hemorrhoidal stage, demographic data, presenting symptoms, complications, duration of hospital stay, postoperative pain, patients' satisfaction and follow-up were obtained. Statistical tests were performed by SPSS 19.0. There was no significant difference between the studied groups according to gender, mean age, preoperative prolapse, pain and pruritus, hemorrhoidal stage and postoperative complications. Preoperative bleeding was more frequent in THD group (p = 0,002). The mean visual analog scale (VAS) pain scores in CH and THD groups on days 1, 2 and 7 were 7.01 vs 5.03, 5.07 vs 2.98, 2.39 vs 0,57 (p = 0,000). Practically, there was no difference in VAS on day 30 and patients' satisfaction at the 18th month. Mean hospital stay was 5,13 (CH) and 3,38 days (THD), p = 0,000. The postoperative follow-up was between 18 and 78 months (mean 46 ± 16 months). During this stage, 5 patients (2,99%) in CH group required surgery for recurrence. In THD group, 3 patients (2,5%), all with 4th-degree hemorrhoids underwent additional procedures (p 0,802). Doppler-guided THD seems to be an efficient and safe option for treatment of hemorrhoids, related to lower postoperative pain and excellent, similar long-term outcomes compared to CH. For advanced grades of hemorrhoids, Doppler-guided THD could be a valuable alternative, but there is a need for patients' selection. (retrospectively registered) researchregistry 3090 .

Sections du résumé

BACKGROUND BACKGROUND
A variety of effective methods for treatment of hemorrhoids has been proposed. In recent years, there has been an increasing number of studies comparing transanal hemorrhoidal dearterilization (THD) and conventional hemorrhoidectomy (CH), but the focus of most studies has been about the early postoperative results. The data about long-term outcomes is still limited. We aimed to compare Doppler-guided THD and CH with regard to early and long-term postoperative results.
METHODS METHODS
The conducted prospective research included 287 patients who underwent CH (167 cases) or Doppler-guided THD with mycopexy (120 patients) between November 2010 and December 2015. Information on hemorrhoidal stage, demographic data, presenting symptoms, complications, duration of hospital stay, postoperative pain, patients' satisfaction and follow-up were obtained. Statistical tests were performed by SPSS 19.0.
RESULTS RESULTS
There was no significant difference between the studied groups according to gender, mean age, preoperative prolapse, pain and pruritus, hemorrhoidal stage and postoperative complications. Preoperative bleeding was more frequent in THD group (p = 0,002). The mean visual analog scale (VAS) pain scores in CH and THD groups on days 1, 2 and 7 were 7.01 vs 5.03, 5.07 vs 2.98, 2.39 vs 0,57 (p = 0,000). Practically, there was no difference in VAS on day 30 and patients' satisfaction at the 18th month. Mean hospital stay was 5,13 (CH) and 3,38 days (THD), p = 0,000. The postoperative follow-up was between 18 and 78 months (mean 46 ± 16 months). During this stage, 5 patients (2,99%) in CH group required surgery for recurrence. In THD group, 3 patients (2,5%), all with 4th-degree hemorrhoids underwent additional procedures (p 0,802).
CONCLUSIONS CONCLUSIONS
Doppler-guided THD seems to be an efficient and safe option for treatment of hemorrhoids, related to lower postoperative pain and excellent, similar long-term outcomes compared to CH. For advanced grades of hemorrhoids, Doppler-guided THD could be a valuable alternative, but there is a need for patients' selection.
TRIAL REGISTRATION BACKGROUND
(retrospectively registered) researchregistry 3090 .

Identifiants

pubmed: 30630463
doi: 10.1186/s12893-019-0469-9
pii: 10.1186/s12893-019-0469-9
pmc: PMC6327383
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Références

Int J Colorectal Dis. 2004 Mar;19(2):176-80
pubmed: 12845454
Dis Colon Rectum. 1992 Aug;35(8):743-6
pubmed: 1643997
Tech Coloproctol. 2007 Dec;11(4):333-8; discussion 338-9
pubmed: 18060529
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006761
pubmed: 19160300
Dis Colon Rectum. 2009 Sep;52(9):1665-71
pubmed: 19690499
Dis Colon Rectum. 2011 Feb;54(2):226-31
pubmed: 21228673
Tech Coloproctol. 2011 Jun;15(2):191-7
pubmed: 21505901
Tech Coloproctol. 2012 Feb;16(1):61-5
pubmed: 22190190
Ann Surg. 2012 May;255(5):840-5
pubmed: 22504188
Dis Colon Rectum. 2013 Apr;56(4):484-90
pubmed: 23478616
Khirurgiia (Sofiia). 2013;(3):4-7
pubmed: 24459760
Colorectal Dis. 2014 May;16(5):373-6
pubmed: 24460621
Dis Colon Rectum. 2014 Mar;57(3):348-53
pubmed: 24509458
J Visc Surg. 2015 Apr;152(2 Suppl):S15-21
pubmed: 25262549
Tech Coloproctol. 2015 Mar;19(3):153-7
pubmed: 25637412
World J Gastrointest Surg. 2016 Jan 27;8(1):1-4
pubmed: 26843909
World J Gastrointest Surg. 2016 Mar 27;8(3):232-7
pubmed: 27022450
Tech Coloproctol. 2016 Dec;20(12):825-833
pubmed: 27888438
Int J Surg Case Rep. 2017;30:73-75
pubmed: 27960130
Tech Coloproctol. 2017 May;21(5):337-344
pubmed: 28451767
Am J Gastroenterol. 1995 Apr;90(4):610-3
pubmed: 7717320

Auteurs

V Popov (V)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

A Yonkov (A)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

E Arabadzhieva (E)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria. elena_arabadjieva@abv.bg.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria. elena_arabadjieva@abv.bg.

E Zhivkov (E)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

S Bonev (S)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

D Bulanov (D)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

V Tasev (V)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

G Korukov (G)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

L Simonova (L)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

N Kandilarov (N)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.

A Taseva (A)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.

V Dimitrova (V)

Department of General and Hepato-pancreatic Surgery, University Hospital "Alexandrovska", 1 Georgi Sofiiski Str, 1431, Sofia, Bulgaria.
Medical University-Sofia, 15 Acad. I. E. Geshov Bul, 1431, Sofia, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH